Merck IIT: RRP Pembro and Lenvatinib

Abroad (travel likely)RecruitingPHASE2

Conditions

Human Papilloma Virus · Recurrent Respiratory Papillomatosis · Pulmonary Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Yale University, New Haven, Connecticut, United States
Contact: Study coordinator (Carole Ramm) · carole.ramm@yale.edu · 203-785-4095
Contact: Principal Investigator (Sara Pai, MD, Phd)

Study leads

Sara I Pai, MD, PHD
Principal Investigator
Yale University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

HPV · Throat Cancer · Oropharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE2

Basking Ridge, United States · Middletown, United States

Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV Vaccination

Human Papilloma Virus Infection Type 16

Abroad (travel likely)RecruitingPHASE2

Antwerp, Belgium · Ghent, Belgium

Unidos Contra el VPH

Human Papilloma Virus (HPV) · Cervical Cancers

Abroad (travel likely)Recruiting

El Paso, United States

Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma

Oropharyngeal Carcinoma · Human Papilloma Virus

Abroad (travel likely)Recruiting

Palo Alto, United States